Factors predicting dropout from treatment in a sample of substance-abusing personality-disordered patients;Fattori predittivi di dropout dal trattamento in comunità terapeutica in un campione di pazienti con disturbo da uso di sostanze e gravi disturbi della personalità

Italian Journal of Psychopathology

Volumn 11, Issue 4, 2005, Pages 456-463

  Madeddu, Fabio ^a   Prunas, A ^a   Mantelli, M ^a   Ravera, F ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Centro per lo Studio dei Disturbi di Personalità CREST   (Italy)

Author keywords

Substance use disorders personality disorders; Treatment completion; Treatment retention

Indexed keywords

ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTCOME ASSESSMENT; PERSONALITY DISORDER; PREVALENCE; PSYCHOPATHY; RESIDENTIAL CARE; SUBSTANCE ABUSE;

EID: 33646019829     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Madeddu F. Le strutture terapeutiche per il trattamento della tossicodipendenza: verso la trasformazione delle comunità. In: Vigorelli M, editor. Il lavoro della cura nelle istituzioni. Progetti, gruppi e contesti nell'intervento psicologico. Milano, Franco Angeli 2005, p. 389-403.
2. Keen J, Oliver P, Rowse G, Mathers N. Residential rehabilitation for drug users: a review of 13 months' intake to a therapeutic community. Family Practice 2001;18:545-8.
3. Ward A, Hall W, Mattick R. Role of maintenance treatment in opioid dependence. Lancet 1999;353:221-6.
4. Martinez-Raga J, Marshall EJ, Keaney F, Ball D, Strang J. Unplanned versus planned discharges from in-patient alcohol detoxification: retrospective analysis of 470 first-episode admissions. Alcohol Alcohol 2002;37:277-81.
5. Armenian SH, Chutuape MA, Stitzer ML. Predictors of discharges against medical advice from a short-term hospital detoxification unit. Drug Alcohol Depend 1999;56:1-8.
6. Jeremiah J, O'Sullivan P, Stein MD. Who leaves against medical advice? J Gen Intern Med 1995;10:403-5.
7. Greenberg WM, Otero J, Villanueva L. Irregular discharges from a dual diagnosis unit. Am J Drug Alcohol Abuse 1994;20:355-71.
8. Claus RE, Kindleberger LR, Dugan MC. Predictors of attrition in a longitudinal study of substance abusers. J Psychoactive Drugs 2002;34:69-74.
9. De los Cobos JP, Trujols J, Ribalta E, Casas M. Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice. Am J Drug Alcohol Abuse 1997;23:267-79.
10. Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993;30:357-68.
11. Cook CA, Booth BM, Blow FC, McAleenan KA, Bunn JY. Risk factors for AMA discharge from VA inpatient alcoholism treatment programs. J Subst Abuse Treat 1994;2:239-45.
12. Deren S, Goldstein MF, Des Jarlais DC, Richman BL, Kang S, Flom PL. Drug use, HIV-related behaviors and drop-out status of new admission and re-admission to methadone treatment. J Subst Abuse Treat 2001;20:185-9.
13. Beck NC, Shekim W, Fraps C, Borgmeyer A, Witt A. Prediction of discharges against medical advice from an alcohol and drug misuse treatment program. J Stud Alcohol 1983;44:171-80.
14. Kokkevi A, Stefanis N, Anastasopoulou E, Kostogianni C. Personality disorders in drug abusers: prevalence and their association with Axis I disorders as predictors of treatment retention. Addict Behav 1998;23:841-53.
15. Martinez-Raga J, Marshall EJ, Keaney F, Best D, Ball D, Strang J. Hepatitis B and C in alcohol-dependent patients admitted to a UK alcohol inpatient treatment unit. Addict Biol 2001;6:363-72.
16. Haller DL, Miles DR, Dawson KS. Psychopathology influences treatment retention among drug-dependent women. J Subst Abuse Treat 2002;23:431-6.
17. Wexler HK, De Leon G. The therapeutic community: multivariate prediction of retention. Am J Drug Alcohol Abuse 1977;4:145-51.
18. Madeddu F, Movalli MG, Prunas A. I disturbi psichiatnci di Asse I e Asse II (DSM IV) nell'alcoldipendenza. In: Manzato E, Barbera G, editors. La comorbilità psichiatrica nell'alcoldipendenza. Atti della Riunione Monotematica della Società Italiana di Alcologia, Zevio (VR), 5 dicembre 2000, p. 17-37.
19. Drake RE, Mueser KT, Clark RE, Wallach MA. The course, treatment, and outcome of substance disorder in person with severe mental illness. Am J Orthopsychiatry 1996;66:42-51.
20. Moos RH, Moos BS, Finney JW. Predictors of deterioration among patients with substance-use disorders. J Clin Psychol 2001;57:1403-19.
21. Thomas VH, Melchert TP, Banken JA. Substance dependence and personality disorders: comorbidity and treatment outcome in an inpatient treatment population. J Stud Alcohol 1999;60:271-7.
22. Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001;61:271-80.
23. Ravndal E, Vaglum P. The influence of personality disorders on treatment completion in a hierarchical therapeutic community for drug abusers: a prospective study. Eur Addict Res 1995;1:178-86.
24. Hatzitaskos P, Soldatos CR, Kokkevi A, Stefanis CN. Substance abuse patterns and their associations with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder. Compr Psychiatry 1999;40:278-82.
25. Galen LW, Brower KJ, Gillespie BW, Zucker RA. Sociopathy, gender and treatment outcome among outpatients substance abusers. Drug Alcohol Depend 2000;61:23-33.
26. Haro G, Mateu C, Martinez Raga J, Valderrama JC, Castellano M, Cervera G. The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification. Eur Psychiatry 2004;19:187-92.
27. Van Stelle KR, Blumer C, Moberg DP. Treatment retention of dually diagnosed offenders in an institutional therapeutic community. Behav Sci Law 2004;22:585-97.
28. Edens JF, Peters RH, Hills HA. Treating prison inmates with co-occurring disorders: An integrative review of existing programs. Behav Sci Law 1997;15:439-57.
29. Linehan MM. Trattamento cognitivo-comportamentale del disturbo borderline. Milano: Raffaello Cortina Editore 2001.
30. rd Ed. Revised (DSM III-R). Washington D.C.: American Psychiatric Press 1987.
31. Bond M, Vaillant JS. An empirical study of the relationship between diagnosis and defence style. Arch Gen Psychiatry 1986;43:285-8.
32. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID II), Version 2.0. New York, NY: Biometric Research Department, New York State Psychiatric Hospital 1994.
33. Miller W, Rollnick S. Motivational interviewing. Preparing people to change addictive behavior. New York: The Guilford Press 1991.
34. (Tr. it.: Il colloquio di motivazione. Tecniche di counselling per problemi di alcol e di altre dipendenze. Trento: Erickson 1994).
35. Lingiardi V, Madeddu F. I meccanismi di difesa. Teoria, valutazione, clinica. Milano: Raffaello Cortina Editore 2002.
36. Madeddu F, Prunas A. Meccanismi di difesa e alcol. Teoria e ricerca empirica. In: Cerbini C, Biaginti CM, Dimauro PE, editors. Alcologia oggi. Nuove tendenze tra clinica ed ecologia. Milano: Franco Angeli 2003, p. 55-62.
37. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer Verlag 1991.
38. Saunders B, Wilkinson E, Phillips M. The impact of a brief motivational intervention with opiate users attending methadone programme. Addiction 1995;90:415-24.
39. th Ed. New York: Wiley 1994, p. 270-376.
40. Mueser KT, Bennet M, Kushner MG. Epidemiology of substance use disorders among persons with chronic mental illnesses. In: Lehman AF, Dixon LB, editors. Double jeopardy: chronic mental illness and substance use disorders. Chur Switzerland: Harwood 1995, p. 9-25.
41. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1999;9:199-213.
42. Consoli A, Bennardo A. Diagnosi e valutazione nelle tossicodipendenze e nell'alcolismo. A.S.I. Addiction Severity Index. Roma: Centro Scientifico Editore 2001.
43. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc. 1996.